What is the ticker symbol for Arcellx?

Arcellx trades under the ticker ACLX on NASDAQ.

What sector does Arcellx operate in?

Arcellx is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ACLX in a portfolio?

PortView shows ACLX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Arcellx (ACLX) Stock Analysis

NASDAQHealthcareBiotechnology

$115.07+0.02%

1-year price historyRange $52.80 – $115.10

52-week range$115.07

$50.85$115.13

What Arcellx does

Arcellx, Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering immunotherapeutic solutions for patients battling cancer and other intractable diseases. A cornerstone of their pipeline is CART-ddBCMA, an advanced ddCAR product candidate currently undergoing a Phase 1 clinical trial. This investigational treatment targets individuals suffering from relapsed or refractory multiple myeloma (MM). Beyond their lead candidate, Arcellx is also advancing ACLX-001, an immunotherapy composed of ARC-T cells and bi-valent SparX proteins engineered to combat r/r MM by targeting BCMA. Their development efforts extend to ACLX-002 and ACLX-003, designed to address relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), alongside a broader portfolio of additional AML/MDS candidates and programs focused on solid tumors. The company, headquartered in Gaithersburg, Maryland, was established in 2014. It operated as Encarta Therapeutics, Inc. before adopting its current name, Arcellx, Inc., in January 2016.

Key metrics

Market cap

$6.73B

P/E (TTM)

-28.27

EPS (TTM)

$-4.07

Beta

0.25

Dividend yield

0.00%

Revenue / share

$0.40

50-day avg

$112.62

200-day avg

$84.15

52-week high

$115.13

52-week low

$50.85

CEO

Rami Elghandour

ETFs linked to ACLX

Broad-market and Healthcare sector ETFs an investor holding Arcellx is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ACLX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ACLX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Arcellx?: Arcellx trades under the ticker ACLX on NASDAQ.
Which exchange is ACLX listed on?: ACLX is listed on NASDAQ.
What sector does Arcellx operate in?: Arcellx is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ACLX in a portfolio?: PortView shows ACLX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.